Association of Delayed Denosumab Dosing with Increased Risk of Fractures: A Population-Based Retrospective Study
Delayed denosumab dosing, even by 1 to 3 months, was significantly associated with increased fracture risk. Maintaining the correct dosing schedule should be emphasized when starting denosumab.
Authors
- Seol A Jang (ORCID: https://orcid.org/0000-0003-1634-1865)
- Namki Hong (ORCID: https://orcid.org/0000-0002-8246-1956)
- Gi Hyeon Seo (ORCID: https://orcid.org/0000-0001-7414-0258)
- Yumie Rhee (ORCID: https://orcid.org/0000-0003-4227-5638)
- Kyoung Min Kim (ORCID: https://orcid.org/0000-0001-8150-0266)
- Chul Sik Kim (ORCID: https://orcid.org/0000-0003-0855-6348)
- Seok Won Park (ORCID: https://orcid.org/0000-0002-7522-2594)
- Steven R. Cummings
Institutions
- University of California, San Francisco (US)
- Yonsei University (KR)
- Severance Hospital (KR)
- Health Insurance Review and Assessment Service (KR)
Publication Details
- Journal
- Endocrinology and Metabolism
- Published
- 2024-11-21
- DOI
- https://doi.org/10.3803/enm.2024.2047
- Citations
- 3
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- Yonsei University
- Yonsei University College of Medicine